NRx Pharmaceuticals, Inc. (NRXP)

NASDAQ: NRXP · IEX Real-Time Price · USD

4.300

-0.600 (-12.24%)

At close: Apr 16, 2024, 4:00 PM

4.270

-0.030 (-0.70%)

After-hours: Apr 16, 2024, 5:32 PM EDT

NRx Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Selling, General & Admin	14.22	27.31	74.94	11.44	2.77	1.01	0.13
Research & Development	13.37	17.03	20.26	10.63	3.5	0	0
Other Operating Expenses	0.25	0	20.6	29.33	0	0	0
Operating Expenses	27.84	44.34	115.8	51.39	6.26	1.01	0.13
Operating Income	-27.84	-44.34	-115.8	-51.39	-6.26	-1.01	-0.13
Interest Expense / Income	0.12	0	0.02	0.06	0.3	0	0
Other Expense / Income	2.19	-4.58	-22.75	0.33	0.16	-1.09	-0.03
Pretax Income	-30.15	-39.75	-93.06	-51.78	-6.73	0.08	-0.11
Income Tax	0	0	0	0	0	0.02	0
Net Income	-30.15	-39.75	-93.06	-51.78	-6.73	0.07	-0.11
Preferred Dividends	0.01	0	255.82	0	0	0	0
Net Income Common	-30.16	-39.75	-348.89	-51.78	-6.73	0.07	-0.11
Shares Outstanding (Basic)	8	7	5	3	1	0	0
Shares Outstanding (Diluted)	8	7	5	3	1	0	0
Shares Change	15.20%	40.17%	36.90%	220.58%	308.88%	38.42%	-
EPS (Basic)	-4.00	-6.00	-19.80	-15.10	-6.30	-2.90	-0.60
EPS (Diluted)	-4.00	-6.00	-19.80	-15.10	-6.30	-2.90	-0.60
Free Cash Flow	-21.66	-39.77	-37.71	-2.27	-5.55	-0.47	-0.14
Free Cash Flow Per Share	-2.86	-6.05	-8.04	-0.66	-5.19	-1.81	-0.72
Effective Tax Rate	-	-	-	-	-	19.79%	-
EBITDA	-30.03	-39.75	-93.04	-51.72	-6.43	0.08	-0.11
Depreciation & Amortization	0.01	0	0	0	0	0	0
EBIT	-30.03	-39.75	-93.05	-51.72	-6.43	0.08	-0.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).